MSG
PJP icon

Main Street Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Main Street Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118 Sell
1
-105
-99% -$11.4K ﹤0.01% 815
2026
Q1 		$11K Buy
+106
New +$11.2K ﹤0.01% 527

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
CI
Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return

Main Street Group's PJP Position: Q2 2026 in Review

Main Street Group reduced its Invesco Pharmaceuticals ETF (PJP) stake by 99% in Q2 2026, selling an estimated $11.4K and leaving 1 share worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Main Street Group first reported a position in PJP in Q1 2026 and has held it in 2 quarters since. The position peaked at $11K in Q1 2026. 16 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Main Street Group held 1 share of Invesco Pharmaceuticals ETF worth $118 as of Q2 2026.
  • Main Street Group sold 105 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $11.4K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #815 holding.
  • Main Street Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
  • Main Street Group's Invesco Pharmaceuticals ETF position peaked at $11K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.